Synthetic Aperture Radar Detection of Breast Tumours
MARIA
Post-CE Marking Continuing Evaluation of Multi-Static Microwave Imaging of the Female Breast in Controlled Trial to Identify Optimum Use of the MARIA Platform in the Clinical Workflow
1 other identifier
observational
264
1 country
1
Brief Summary
The study will seek to understand the effective use of a novel Microwave Radar Breast Imaging System in a Symptomatic Breast Care Clinic. The MARIA Imaging system uses low level non--ionising radiation (radio wave) signals to scan the breast tissue volume and to provide a visual image of areas of varying tissue permittivity value within the volume. These areas of varying permittivity can be shown as a two or three dimensional image and used in conjunction with the X-Ray mammogram and ultrasound scans to provide another level of diagnosis to the radiologist.The system works equally well in both dense and lucent breast types and can in particular provide insight into the diagnosis in dense tissue cases. The trial will accept symptomatic cases with suspected cancer, cysts or fibroadenoma. The trial will use the images produced by the MARIA system and compare them to the images obtained using X-Ray mammography. The results of the comparison will be assessed to understand the effectiveness of the MARIA image in assisting with the identification and location of suspected lesions for further specific analysis using Ultrasound/Biopsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 14, 2015
CompletedFirst Posted
Study publicly available on registry
July 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedAugust 17, 2018
August 1, 2018
1.9 years
April 14, 2015
August 16, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity of Radio-Wave imaging in the diagnostic breast care clinic
The research will seek to measure the added value of a radiowave imaging procedure in a diagnostic breast care clinic in improving accuracy of diagnostic outcomes. In particular it will evaluate the ability of radiowave imaging in the younger patient to demonstrate the presence of lesions in tissue which is dense. As a nonionizing radiation it also has potential to be the bulk imaging method of choice in women under 40 who would only be offered a mammogram where the risk benefit justified it, i.e. with a probability of malignancy.
Duration of the Study, 6 month interval progress assessment
Secondary Outcomes (1)
Comparison of radio wave image sensitivity in Dense Tissue BIRADS c and d as compared to X-Ray Mammography
Study result assessed every 6 months
Study Arms (1)
Cancer
Patients attending One-stop Symptomatic Breast Care clinics with suspicion of a breast lesion in one or both breasts.
Eligibility Criteria
Female Patients with suspicion of breast lesions attending One-Stop Breast Care diagnostic clinics
You may qualify if:
- Referred for diagnosis because of a reported symptom of breast disease
- No previous treatment or biopsy
- Breast size 32A to breast size 42DD
- Able to lie prone on a couch for 10 minutes
- Able to remain reasonably still for 2 minutes
You may not qualify if:
- Breast implants
- Recent Biopsy
- Extremely small or extremely large breasts
- Presence of metal or blood lesion (haematoma)
- Breathlessness or severe arthritis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Micrima, Ltd.lead
Study Sites (1)
North Bristol Trust NHS Breast Care Clinic
Bristol, BS10 5NB, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Michael H Shere, M.R.C.S
North Bristol NHS Trust, United Kingdom
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2015
First Posted
July 9, 2015
Study Start
April 1, 2015
Primary Completion
March 1, 2017
Study Completion
August 1, 2018
Last Updated
August 17, 2018
Record last verified: 2018-08